Cargando…
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
INTRODUCTION: Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of International Normalized Ratio (INR) 2.0–3.0 over 65%–7...
Autores principales: | Rivera-Caravaca, José Miguel, Marín, Francisco, Esteve-Pastor, María Asunción, Gálvez, Josefa, Lip, Gregory Y.H., Vicente, Vicente, Roldán, Vanessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924708/ https://www.ncbi.nlm.nih.gov/pubmed/31843852 http://dx.doi.org/10.1136/bmjopen-2019-033712 |
Ejemplares similares
-
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022) -
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2017) -
Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022) -
Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA
(2)
DS
(2)‐VASc Scores
por: Rivera‐Caravaca, José Miguel, et al.
Publicado: (2017) -
Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists
por: Roldán, Vanessa, et al.
Publicado: (2022)